A citation-based method for searching scientific literature

William Dauer, Serge Przedborski. Neuron 2003
Times Cited: 3508







List of co-cited articles
488 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
813
8


Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
8

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
862
7

Animal models of Parkinson's disease.
Fabio Blandini, Marie-Therese Armentero. FEBS J 2012
240
6

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
6


Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
6

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
6

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
6

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Emily M Rocha, Briana De Miranda, Laurie H Sanders. Neurobiol Dis 2018
280
6

Protocol for the MPTP mouse model of Parkinson's disease.
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
631
6


Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
Lisa Fellner, Regina Irschick, Kathrin Schanda, Markus Reindl, Lars Klimaschewski, Werner Poewe, Gregor K Wenning, Nadia Stefanova. Glia 2013
397
5

Parkinson's disease: animal models and dopaminergic cell vulnerability.
Javier Blesa, Serge Przedborski. Front Neuroanat 2014
290
5


Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Julie Lotharius, Patrik Brundin. Nat Rev Neurosci 2002
788
5

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
5

Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
5

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
Laura A Volpicelli-Daley, Kelvin C Luk, Tapan P Patel, Selcuk A Tanik, Dawn M Riddle, Anna Stieber, David F Meaney, John Q Trojanowski, Virginia M-Y Lee. Neuron 2011
915
5

Non-motor features of Parkinson disease.
Anthony H V Schapira, K Ray Chaudhuri, Peter Jenner. Nat Rev Neurosci 2017
614
5

The many faces of α-synuclein: from structure and toxicity to therapeutic target.
Hilal A Lashuel, Cassia R Overk, Abid Oueslati, Eliezer Masliah. Nat Rev Neurosci 2013
920
4



Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
4

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H Bernheimer, W Birkmayer, O Hornykiewicz, K Jellinger, F Seitelberger. J Neurol Sci 1973
4

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
4

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
Latha Devi, Vijayendran Raghavendran, Badanavalu M Prabhu, Narayan G Avadhani, Hindupur K Anandatheerthavarada. J Biol Chem 2008
688
4

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
738
4

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
4

A guide to neurotoxic animal models of Parkinson's disease.
Kim Tieu. Cold Spring Harb Perspect Med 2011
278
4

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
521
4

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
Lee J Martin, Yan Pan, Ann C Price, Wanda Sterling, Neal G Copeland, Nancy A Jenkins, Donald L Price, Michael K Lee. J Neurosci 2006
483
4

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Wei Zhang, Tongguang Wang, Zhong Pei, David S Miller, Xuefei Wu, Michelle L Block, Belinda Wilson, Wanqin Zhang, Yong Zhou, Jau-Shyong Hong,[...]. FASEB J 2005
848
4


The clinical symptoms of Parkinson's disease.
Sigurlaug Sveinbjornsdottir. J Neurochem 2016
393
4

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel,[...]. Mov Disord 2008
3

alpha-synuclein promotes mitochondrial deficit and oxidative stress.
L J Hsu, Y Sagara, A Arroyo, E Rockenstein, A Sisk, M Mallory, J Wong, T Takenouchi, M Hashimoto, E Masliah. Am J Pathol 2000
530
3

Mechanisms underlying inflammation in neurodegeneration.
Christopher K Glass, Kaoru Saijo, Beate Winner, Maria Carolina Marchetto, Fred H Gage. Cell 2010
3

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
G T Liberatore, V Jackson-Lewis, S Vukosavic, A S Mandir, M Vila, W G McAuliffe, V L Dawson, T M Dawson, S Przedborski. Nat Med 1999
835
3

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Richard Gordon, Eduardo A Albornoz, Daniel C Christie, Monica R Langley, Vinod Kumar, Susanna Mantovani, Avril A B Robertson, Mark S Butler, Dominic B Rowe, Luke A O'Neill,[...]. Sci Transl Med 2018
300
3




Alzheimer's disease and Parkinson's disease.
Robert L Nussbaum, Christopher E Ellis. N Engl J Med 2003
807
3

Genetic animal models of Parkinson's disease.
Ted M Dawson, Han Seok Ko, Valina L Dawson. Neuron 2010
506
3


Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein.
Ken Nakamura, Venu M Nemani, Farnaz Azarbal, Gaia Skibinski, Jon M Levy, Kiyoshi Egami, Larissa Munishkina, Jue Zhang, Brooke Gardner, Junko Wakabayashi,[...]. J Biol Chem 2011
398
3

Mitochondrial complex I deficiency in Parkinson's disease.
A H Schapira, J M Cooper, D Dexter, J B Clark, P Jenner, C D Marsden. J Neurochem 1990
3

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.